价格

ELPEN Pharmaceutical Co., Inc.

ACTIVE

希腊www.elpen.grPrivate501–1,000 名员工成立于: 1965-01-01

概览

试验阶段分布

阶段

试验数

占比

3 期

4.0%

不适用

2.0%

1 期

2.0%

2 期

2.0%

4 期

2.0%

试验状态分布

进行中（未招募）

10.0%

已完成

60.0%

尚未招募

6.0%

招募中

10.0%

撤回

14.0%

药物批准

按机构分类的批准

PHILIPPINES

Philippines FDA

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

PERAMPANEL ELPEN 12 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2023-07-05

PERAMPANEL ELPEN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2023-07-05

PERAMPANEL ELPEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2023-07-05

PERAMPANEL ELPEN 8 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2023-07-05

PERAMPANEL ELPEN 6 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2023-07-05

PERAMPANEL ELPEN 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

TICAGRELOR ELPEN 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2022-03-01

TICAGRELOR ELPEN 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2022-03-01

资讯

暂无资讯文章

返回机构列表

ELPEN Pharmaceutical Co., Inc.

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（50）

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

Real World Study in Greek Patients With BPH for Disease Control and QoL Under FDC Treatment With Solifenacin/Tamsulosin.

TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.

Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.

Adherence of Iron Succinylate Therapy in Pregnancy

Ezetimibe-Rosuvastatin Evaluation Study

药物批准

按机构分类的批准

近期批准

资讯